On April 9, 2024, a groundbreaking women-only clinical trial unveiled PhaeOptim, a microalgae extract, as a potent supporter of active lifestyles and weight management. Conducted by Microphyt, the double-blind study revealed PhaeOptim’s prowess in enhancing exercise capacity, cardiovascular fitness, and bone health among 37 overweight yet healthy women. Administered alongside a calorie-restricted diet and supervised exercise regimen, PhaeOptim recipients displayed notable reductions in energy and fat intake, alongside a remarkable 2.5-fold increase in aerobic capacity. Lead researcher Dr. Jonathan Maury hailed PhaeOptim’s natural and sustainable profile, calling for further investigations to unlock its full potential in fostering holistic wellness. Published in Nutrients, the study marks a significant stride in promoting healthier living.
Omega-3 Supplementation May Help Slow Down Biological Aging
February 15, 2025
